期刊文献+

24例胃肠道间质瘤的临床病理分析

Clinicopathological and immunohistochemical analysis of gastrointestinal stromal tumors
下载PDF
导出
摘要 目的探讨胃肠道间质瘤(GIST)中CD117、CD34、SMA及S-100的表达以及四个免疫组化标志物的相关性。方法对24例手术切除的GIST复习其临床特点及病理形态,用免疫组化方法检测GIST中CD117、CD34、SMA及S-100的表达。结果免疫组化结果:CD117阳性率79.14%,CD34阳性率79.14%,SMA阳性率54.17%,S-100阳性率12.50%,统计分析结果:CD117与CD34呈正相关性(r=0.495,P=0.014),CD117与S-100负相关(r=-0.427,P=0.038),CD117、CD34、SMA、S-100在良性组、潜在恶性及恶性组比较差异均无统计学意义(P>0.05)。结论结合GIST的临床病理特点,免疫组化CD117和CD34阳性及其相关性是确诊GIST最可靠和最有价值的依据,CD117、CD34、SMA及S-100作为GIST良恶性鉴别参考指标意义不大。 Objective To study the immunohistochemical features of gastrointestinal stromal tumors(GIST).Methods The expressions of CD117、CD34、SMA、S-100 of the GIST were studied by immunohistochemistry method(EliVision plus).Results By immunohistochemical staining detection,the positive expression rates of CD117、CD34、SMA and S-100 in GIST cases were 79.17%,79.17%,54.17% and 12.5%.Conclusion GIST can be identified by the combining applying of CD117、CD34 and SMA、S-100 through the immunohistochemistry method.
出处 《广州医药》 2011年第6期14-17,共4页 Guangzhou Medical Journal
关键词 胃肠间质瘤 病理学 免疫组化 Gastrointestinal stromal tumors Clinical pathology Immunohistochemistry
  • 相关文献

参考文献13

  • 1Liegl-Atzwanger B, Fletcher JA, Fletcher CD. Gastroin- testinal stromal tumors [ J] . VirchowsArchl 2010, 456 (2) : 111-127.
  • 2Miettinen M, Lasota J. Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis [ J ] . Arch Pathol Lab Med, 2006, 130 (10): 1466-1478.
  • 3侯英勇,王坚,朱雄增,杜祥,孙孟红,郑爱华.胃肠道间质瘤76例的临床病理及免疫组织化学特征[J].中华病理学杂志,2002,31(1):20-25. 被引量:231
  • 4Lewin K J, Riddell RH, Weinstein WM, et al. Gastroin- testinal pathological and its Clinical implications [ M ] . New York: Igaku-Shoin, 1992: 284-341.
  • 5Demetri GD, Benjamin RS, Blanke CD, et al. NCCN task force report: management of patients with gastroin- testinal stromal tumor (GIST) -update of the NCCN clin- ical practice guidelines [J] . J Natl Compr Canc Netw, 2007, 5 (Suppl2) : S1-29.
  • 6中国胃肠道间质瘤病理共识意见[J].中华病理学杂志,2007,36(10):704-707. 被引量:109
  • 7Miettinen M, Lasota J. KIT (CD117 ) : a review on ex- pression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation [ J ] . Appl Immu- nohistochem Mol Morphol, 2005, 13 (3) : 205-220.
  • 8周庚寅,翟启辉,张庆慧.诊断免疫组织化学[M].2版.北京:北京大学医学出版社,2008:452.
  • 9施娟红,王妍,何庆泗,李劲松.肠系膜纤维瘤、孤立性纤维性肿瘤和胃肠道间质瘤的免疫组织化学观察[J].中国现代普通外科进展,2010,13(1):28-30. 被引量:2
  • 10Tosoni A, Nicolardi L, Brands AA. Current clinical management of gastrointestinal stromal tumors [ J ] . Ex- pert Rev Antieancer Ther, 2004, 4 (4): 595-605.

二级参考文献55

  • 1贺慧颖,方伟岗,钟镐镐,李燕,郑杰,杜娟,衡万杰,吴秉铨.165例胃肠道间质瘤中c-kit和PDGFRA基因突变的检测和临床诊断意义[J].中华病理学杂志,2006,35(5):262-266. 被引量:73
  • 2杨吉龙,王坚,周晓燕,侯英勇,朱雄增.韧带样型纤维瘤病Wnt通路中APC/β-catenin基因异常[J].中国癌症杂志,2006,16(10):859-863. 被引量:5
  • 3张凡,赵春临,张谢夫.胃肠道间质瘤的研究进展[J].医药论坛杂志,2007,28(12):119-121. 被引量:4
  • 4Stanley R. Hamilton, Laufi A. Aaltonen..消化系统肿瘤病理学和遗传学[M].见:虞积耀主译.世界卫生组织肿瘤分类及诊断标准系列.北京:人民卫生出版社,2006:72.
  • 5West RB, Corless CL, Cheu X, et al. The Novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status [J]. Am J Pathol, 2004, 165 ( 1 ) : 107.
  • 6Hornic JL, Fletcher CDM. The role of KIT in the management of patients with gastrointestinal stromal tumors [J]. Hum Pathol, 2007,38 (5) :679.
  • 7回允中.外科病理学[M].9版.北京:北京大学医学出版,2005:678-679.
  • 8Coffin CM,Hornick JL,Zhou H,et al.Gardner fibroma:a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas[J].Am J Surg Pathol,2007,31(3):410-416.
  • 9Tony LN,Allen MG,Todd SB,et al.Nuclear β-catenin in mesenchymal tumors[J].Modern Pathology,2005,18(3):68-74.
  • 10Andino L,Cagle PT,Bruno M,et al.Pleuropulmonary Desmoid Tumors Immunohistochemical Comparison With Solitary Fibrous Tumors and Assessment of β-Catenin and Cyclin D1 Expression[J].Arch Pathol Lab Med,2006,130(10):1503-1509.

共引文献346

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部